These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11991916)

  • 41. An open study to assess the long-term safety of fluticasone propionate in asthmatic children. International Study Group.
    MacKenzie CA; Tsanakas J; Tabachnik E; Radford M; Berdel D; Götz MH; Parker C
    Br J Clin Pract; 1994; 48(1):15-8. PubMed ID: 8179974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
    Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
    Gershman NH; Wong HH; Liu JT; Fahy JV
    Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenal function in children with severe asthma treated with high-dose inhaled glucocorticoids: recommended screening tests in outpatient conditions.
    Breborowicz A; Niedziela M
    J Pediatr Endocrinol Metab; 2007 Jul; 20(7):781-9. PubMed ID: 17849740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inhaled corticosteroids: first-line therapy in asthma].
    Hajiro T; Ishihara K
    Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis.
    Masoli M; Weatherall M; Holt S; Shirtcliffe P; Beasley R
    Eur Respir J; 2006 Nov; 28(5):960-7. PubMed ID: 16737984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluticasone propionate: safety profile.
    Johnson M
    Cutis; 1996 Feb; 57(2 Suppl):10-2. PubMed ID: 8646863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
    Holliday SM; Faulds D; Sorkin EM
    Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Adrenal insufficiency secondary to the use of inhaled corticosteroids].
    Shukla A; Nørrelund H
    Ugeskr Laeger; 2011 Sep; 173(39):2420-1. PubMed ID: 21958486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
    Malo JL; Cartier A; Ghezzo H; Mark S; Brown J; Laviolette M; Boulet LP
    Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose inhaled fluticasone, adrenal crisis and a fatal accident inquiry.
    Todd G
    Arch Dis Child; 2007 Apr; 92(4):372-3. PubMed ID: 17376953
    [No Abstract]   [Full Text] [Related]  

  • 54. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adrenal insufficiency during inhaled corticosteroid treatment in a child with asthma].
    Bjerre JV; Bender L; Naeraa RW; Rix M
    Ugeskr Laeger; 2008 Jun; 170(24):2161. PubMed ID: 18565305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
    Johnson SR; Marion AA; Vrchoticky T; Emmanuel PJ; Lujan-Zilbermann J
    J Pediatr; 2006 Mar; 148(3):386-8. PubMed ID: 16615973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adrenal suppression with inhaled corticosteroids.
    Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):359-61. PubMed ID: 11730176
    [No Abstract]   [Full Text] [Related]  

  • 58. Starting inhaled corticosteroids in asthma: when, how high, and how long.
    van der Molen T; Kerstjens HA
    Eur Respir J; 2000 Jan; 15(1):3-4. PubMed ID: 10678612
    [No Abstract]   [Full Text] [Related]  

  • 59. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.
    Fukushima C; Matsuse H; Tomari S; Obase Y; Miyazaki Y; Shimoda T; Kohno S
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):646-51. PubMed ID: 12839324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flovent (fluticasone propionate inhalation aerosol).
    Levy DS
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):861-2. PubMed ID: 9215264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.